Haematologica (Dec 2014)

The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia

  • Kaat Durinck,
  • Annelynn Wallaert,
  • Inge Van de Walle,
  • Wouter Van Loocke,
  • Pieter-Jan Volders,
  • Suzanne Vanhauwaert,
  • Ellen Geerdens,
  • Yves Benoit,
  • Nadine Van Roy,
  • Bruce Poppe,
  • Jean Soulier,
  • Jan Cools,
  • Pieter Mestdagh,
  • Jo Vandesompele,
  • Pieter Rondou,
  • Pieter Van Vlierberghe,
  • Tom Taghon,
  • Frank Speleman

DOI
https://doi.org/10.3324/haematol.2014.115683
Journal volume & issue
Vol. 99, no. 12

Abstract

Read online

Genetic studies in T-cell acute lymphoblastic leukemia have uncovered a remarkable complexity of oncogenic and loss-of-function mutations. Amongst this plethora of genetic changes, NOTCH1 activating mutations stand out as the most frequently occurring genetic defect, identified in more than 50% of T-cell acute lymphoblastic leukemias, supporting a role as an essential driver for this gene in T-cell acute lymphoblastic leukemia oncogenesis. In this study, we aimed to establish a comprehensive compendium of the long non-coding RNA transcriptome under control of Notch signaling. For this purpose, we measured the transcriptional response of all protein coding genes and long non-coding RNAs upon pharmacological Notch inhibition in the human T-cell acute lymphoblastic leukemia cell line CUTLL1 using RNA-sequencing. Similar Notch dependent profiles were established for normal human CD34+ thymic T-cell progenitors exposed to Notch signaling activity in vivo. In addition, we generated long non-coding RNA expression profiles (array data) from ex vivo isolated Notch active CD34+ and Notch inactive CD4+CD8+ thymocytes and from a primary cohort of 15 T-cell acute lymphoblastic leukemia patients with known NOTCH1 mutation status. Integration of these expression datasets with publicly available Notch1 ChIP-sequencing data resulted in the identification of long non-coding RNAs directly regulated by Notch activity in normal and malignant T cells. Given the central role of Notch in T-cell acute lymphoblastic leukemia oncogenesis, these data pave the way for the development of novel therapeutic strategies that target hyperactive Notch signaling in human T-cell acute lymphoblastic leukemia.